Literature DB >> 2103394

Primary sclerosing cholangitis: clinical and immunopathological review of 21 cases.

G P Jeffrey1, W D Reed, B H Laurence, K B Shilkin.   

Abstract

Twenty-one patients with primary sclerosing cholangitis were seen during 1979-87. The mean age at onset of disease was 51.7 years (range: 13-78 years) with a male: female ratio of 2.5:1. Six (29%) were asymptomatic at the time of diagnosis. Eleven patients (52%) had ulcerative colitis. Cholangiography demonstrated abnormalities limited to the intrahepatic ducts in 10 cases, with both intrahepatic and extrahepatic involvement in 11. Histological features on liver biopsy included: portal tract inflammation and cholestasis in all; paucity of bile ducts in 56%; piecemeal necrosis in 19% and cirrhosis in 6%. Circulating autoantibodies and elevated serum immunoglobulins were found in half of the patients and HLA-B8 was detected in 53%. A deficiency of circulating CD3 and CD8 cells was not found in the 12 patients tested. The mean follow-up was 51 months (range: 3-180 months). Three patients died from non-hepatic causes and another has received liver transplantation. A Kaplan-Meier curve predicted 70% survival at 72 months.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103394     DOI: 10.1111/j.1440-1746.1990.tb01818.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 3.  The evolution of natural history of primary sclerosing cholangitis.

Authors:  Will R Takakura; James H Tabibian; Christopher L Bowlus
Journal:  Curr Opin Gastroenterol       Date:  2017-03       Impact factor: 3.287

4.  Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis.

Authors:  G P Jeffrey; N R Swanson; L J Yarred; W D Reed
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

5.  Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis.

Authors:  G P Jeffrey; W D Reed; S Carrello; K B Shilkin
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

6.  Sclerosing cholangitis and biliary tract calculi--primary or secondary?

Authors:  C S Pokorny; G W McCaughan; N D Gallagher; W S Selby
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 7.  Pathogenesis of primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Emina Halilbasic; Peter Fickert; Michael Trauner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-12       Impact factor: 3.043

Review 8.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.